Nervosave Therapeutics Overview

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 5

Nervosave Therapeutics General Information

Description

Developer of a gene therapy platform designed to focus on nerve-related disorders such as peripheral neuropathies and neuropathic pain. The company develops therapy for CMT1A patients and beyond for all demyelinating diseases, and also develops discovery programs and acquires demyelinating peripheral neuropathies such as diabetic peripheral neuropathy and Guillain-Barré syndrome, enabling patients with treatments for demyelinating peripheral neuropathies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 371 Rue du Professor Blayac
  • Cédex
  • 34080 Montpellier
  • France
+33 06
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 371 Rue du Professor Blayac
  • Cédex
  • 34080 Montpellier
  • France
+33 06

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nervosave Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 28-Feb-2025 Completed Startup
4. Accelerator/Incubator 11-May-2023 Completed Startup
3. Accelerator/Incubator 24-Jan-2022 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator 01-Jan-2020 Completed Startup
To view Nervosave Therapeutics’s complete valuation and funding history, request access »

Nervosave Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nervosave Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Boost Invest MedVallée Accelerator/Incubator
Westchester County Biosciences Accelerator Accelerator/Incubator
SATT AxLR Accelerator/Incubator
Deeptech Founders Accelerator/Incubator
Business & Innovation Center Accelerator/Incubator
To view Nervosave Therapeutics’s complete investors history, request access »

Nervosave Therapeutics FAQs

  • Where is Nervosave Therapeutics headquartered?

    Nervosave Therapeutics is headquartered in Montpellier, France.

  • What is the size of Nervosave Therapeutics?

    Nervosave Therapeutics has 4 total employees.

  • What industry is Nervosave Therapeutics in?

    Nervosave Therapeutics’s primary industry is Drug Discovery.

  • Is Nervosave Therapeutics a private or public company?

    Nervosave Therapeutics is a Private company.

  • What is Nervosave Therapeutics’s current revenue?

    The current revenue for Nervosave Therapeutics is .

  • Who are Nervosave Therapeutics’s investors?

    Boost Invest MedVallée, Westchester County Biosciences Accelerator, SATT AxLR, Deeptech Founders, and Business & Innovation Center have invested in Nervosave Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process